Orchard Therapeutics
Orchard Therapeutics is a biotechnology company developing gene therapies for rare diseases.
5
Funding Rounds
$459.7m
Money raised
Overview
Orchard Therapeutics is a biotechnology company developing gene therapies for rare diseases.
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Be* Au | - | - | |
| Bo*** Ga**** | - | - | linkedin twitter |
| An**** Sp**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Bo*** Ga**** | - | - | linkedin twitter |
| St**** Al*** | - | - | - |
| Al**** Se*** |
|
- | - |
| Ch Ro | - | - | - |
| Ji* Ge* | - | - | - |
| Ma** Du | - | - | - |
| Jo** Cu* | - | - | - |
| Jo**** Be** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Orchard Therapeutics has raised a total of $309.66m in funding over 5 rounds.
Key Insights:
- Orchard Therapeutics Venture round, February 5, 2021: $150m
- Orchard Therapeutics Series B round, December 20, 2017: $110m
- Orchard Therapeutics Grant (money), November 23, 2016: $20m
- Orchard Therapeutics Series A round, May 3, 2016: $29.66m
- Orchard Therapeutics funding round, August 2018: $150m
Orchard Therapeutics Venture round, February 5, 2021
$150m
Orchard Therapeutics Series B round, December 20, 2017
$110m
Orchard Therapeutics Grant (money), November 23, 2016
$20m
Orchard Therapeutics Series A round, May 3, 2016
$29.66m
Orchard Therapeutics funding round, August 2018
$150m
Industries
Orchard Therapeutics is active in the following industries: